Section 10Sec./Art. 10

COVID-19 National Vaccine Indemnity Fund. -The COVID-19 National Vaccine Indemnity Fund, which shall be administered by the PhilHealth, is hereby established as a trust fund to compensate any person inoculated through the COVID-19 Vaccination Program, in case of death, permanent disability or hospital confinement for any SAEs:Provided,That in case of death and permanent disability, PhilHealth is hereby authorized to pay compensation from the indemnity fund.

The amount of Five hundred million pesos (P500,000,000.00) is hereby authorized to augment the funds of PhilHealth for this purpose which shall be sourced from the Contingent Fund, as provided under Republic Act No. 11518 or the General Appropriations Act of 2021.

The indemnity fund shall be valid and available for release and disbursement until terminated by the

President of the Philippines, based on the recommendation of the Permanent Committee, which was created under Executive Order No. 292, s. 1987, that the purpose for which it has been established has been fulfilled. The Permanent Committee shall also determine the amount that shall revert to the National Treasury upon its termination. The PhilHealth, in consultation with the DOH, the Department of Finance, the Department of Budget and Management and the NTF, shall issue the necessary guidelines for the planning, administration, and monitoring of the utilization of the fund, including the determination of its sufficiency.

For this purpose, the IATF-EID shall establish a Special Task Group composed of medical and vaccine experts with proven track record who will be in charge of monitoring the probable adverse effects following immunization from COVID-19. The Special Task Group shall promulgate the necessary guidelines on the monitoring, evaluation, investigation and reporting mechanism to be followed by all LGUs:Provided,That this section shall be vaid and in effect for a period of five (5) years from the effectivity of this Act or until the government has declared the completion of the COVID-19 Vaccination Program, whichever comes earlier.